Inactivation of Heparin by Cationically Modified Chitosan
This study was performed to evaluate the ability of N-(2-hydroxypropyl)-3-tri methylammonium chitosan chloride (HTCC), the cationically modified chitosan, to form biologically inactive complexes with unfractionated heparin and thereby blocking its anticoagulant activity. Experiments were carried out...
Main Authors: | Barbara Lorkowska-Zawicka, Kamil Kamiński, Justyna Ciejka, Krzysztof Szczubiałka, Magdalena Białas, Krzysztof Okoń, Dariusz Adamek, Maria Nowakowska, Jacek Jawień, Rafał Olszanecki, Ryszard Korbut |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2014-06-01
|
Series: | Marine Drugs |
Subjects: | |
Online Access: | http://www.mdpi.com/1660-3397/12/7/3953 |
Similar Items
-
IS THE INCIDENCE TREND OF HEPARIN-INDUCED THROMBOCYTOPENIA DECREASED BY THE INCREASED USE OF LOW-MOLECULAR-WEIGHT-HEPARIN?
by: Fahad Al-Eidan
Published: (2015-04-01) -
The Inhibitory Effect of Protamine on Platelets is Attenuated by Heparin without Inducing Thrombocytopenia in Rodents
by: Joanna Miklosz, et al.
Published: (2019-09-01) -
Does ‘heparin-induced thrombocytopenia’ hit our minds?
by: Arun R. Thangavel, et al.
Published: (2016-08-01) -
Comparison of Pregnancy Outcomes of Low Molecular Weight Heparin with Unfractionated Heparin in the Treatment of Recurrent Abortion Secondary to Antiphospholipid Syndrome
by: M Janghorbani, et al.
Published: (2013-09-01) -
Precipitation and Neutralization of Heparin from Different Sources by Protamine Sulfate
by: John Hogwood, et al.
Published: (2017-07-01)